Resultados de la búsqueda 151-160 of 5414 for Ichthyosis

1. Cirugía - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. The purposes of this study are to determine whether maternal T cells are activated and expand after in utero intervention, and to determine ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

3. Cirugía - Ensayos clínicos - Mayo Clinic

   Scottsdale/Phoenix, Ariz. The main objective of the Brain Tumor Repository is to allow access to coded patient data by researchers both inside and outside of ...

4. Cirugía - Ensayos clínicos - Mayo Clinic

   To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

5. Cirugía - Ensayos clínicos - Mayo Clinic

   Pre-operative Vs. Post-operative Radiosurgery For Metastatic Brain Tumors. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this ...

6. Cirugía - Ensayos clínicos - Mayo Clinic

   This proposal will begin intense lymphedema screening and identify baseline characteristics potentially predisposing someone to lymphedema, and identify ...

7. Cirugía - Ensayos clínicos - Mayo Clinic

   Cancer is caused by changes (mutations) to genes that control the way cells function. Tumors with high number of mutations may respond well to immunotherapy.

8. Cirugía - Ensayos clínicos - Mayo Clinic

   Aims, purpose, or objectives: We will conduct a pilot trial to test whether caregivers of heart and lung transplant candidates who receive wellness coaching ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...